Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
NCT00150384
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated
- Subjects must satisfy the blood pressure and LDL-C inclusion criteria for their respective Cardiovascular Risk group determined at screening
- Subjects currently being treated with concomitant amlodipine and atorvastatin therapy,
including Caduet
- Subjects with blood pressure at goal
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Jonesboro, Arkansas
- Little Rock, Arkansas
- Garden Grove, California
- Long Beach, California
- Tustin, California
- Aventura, Florida
- Ft. Lauderdale, Florida
- Miami, Florida
- Pembroke Pines, Florida
- Atlanta, Georgia
- Decatur, Georgia
- Bossier City, Louisiana
- Fair Haven, Michigan
- Livonia, Michigan
- Jackson, Mississippi
- Jackson, Mississippi
- Excelsior Springs, Missouri
- Berlin, New Jersey
- Elizabeth, New Jersey
- Princeton, New Jersey
- South Bound Brook, New Jersey
- Binghamton, New York
- Monroe, North Carolina
- Winston-Salem, North Carolina
- Cincinnati, Ohio
- Dayton, Ohio
- Eugene, Oregon
- Bensalem, Pennsylvania
- Kingsport, Tennessee
- Beaumont, Texas
- Colleyville, Texas
- Houston, Texas
- Temple, Texas
- Norfolk, Virginia
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Red Deer, Alberta
- Campbell River, British Columbia
- Chilliwack, British Columbia
- New Westminster, British Columbia
- North Vancouver, British Columbia
- Quesnel, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Vancouver, British Columbia
- Winnipeg, Manitoba
- Winnipeg, Manitoba
- Antigonish, Nova Scotia
- Digby, Nova Scotia
- Halifax, Nova Scotia
- Halifax, Nova Scotia
- Truro, Nova Scotia
- Wolfville, Nova Scotia
- Alymer, Ontario
- Corunna, Ontario
- Exeter, Ontario
- Hamilton, Ontario
- Kingston, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- London, Ontario
- North York, Ontario
- North York, Ontario
- Oshawa, Ontario
- Oshawa, Ontario
- Peterborough, Ontario
- Sarnia, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Waterloo, Ontario
- Weston, Ontario
- Whitby, Ontario
- Charlottetown, Prince Edward Island
- Bonaventure, Quebec
- Chomedy, Quebec
- Gatineau, Quebec
- Granby, Quebec
- Longueuil, Quebec
- Montreal, Quebec
- Montreal, Quebec
- Pointe-Claire, Quebec
- Sherbrooke, Quebec
- St Jerome, Quebec
- St-Georges Ouest, Quebec
- St-Marc Des Carrieres, Quebec
- St. Lambert, Quebec
- Ste-foy, Quebec
- Regina, Saskatchewan
- Quebec,
- Quebec,
- Quebec,
- Rimouski,
- St-Gedeon Beauce,
- St. John's,
- St. John's,
- St. John's,
- Ayr, Ayrshire
- Sandy, Bedfordshire
- Peterborough, Cambs
- Thornhill, Cardiff
- Fowey, Cornwall
- Darlington, County Durham
- Darlington, County Durham
- Paignton, Devon
- Plymouth, Devon
- Bournemouth, Dorset
- Angus, Dundee
- Central Milton Keyne, England
- Lancaster, England
- Surrey, England
- Wishaw, Lanarkshire, England
- Leigh-on-sea, Essex
- nEWPORT, gWENT
- Letchworth, Hertfordshire
- Canterbury, Kent
- Whitstable, Kent
- Blackpool, Lancashire
- Spalding, Lincolnshire
- Bangor, Belfast, Northern Ireland
- Coatbridge, Scotland
- Glasgow, Scotland
- Frome, Somerset
- Stairfoot, Barnsley, South Yorkshire
- Weybridge, Surrey
- Leeds, West Yorkshire
- Sheffield, Yorkshire
- Aberdeen,
- Berkshire,
- Cambridge,
- Canterbury,
- Coventry,
- Coventry,
- Dorking,
- Dundee,
- Glasgow,
- Glasgow,
- Glasgow,
- Hertfordshire,
- Kent,
- Leeds,
- Newcastle-upon-Tyne,
- Newcastle-upon-Tyne,
- Nottingham,
- Rochdale,
- Shrewsbury,
- Stourbridge,
- Swanley,
- Swindon,
- Birmingham, Alabama
- Birmingham, Alabama
- Huntsville, Alabama
- Little Rock, Arkansas
- Los Angeles, California
- Oakland, California
- Pico Rivera, California
- Bridgeport, Connecticut
- Washington, District of Columbia
- Washington, District of Columbia
- Aventura, Florida
- Gainesville, Florida
- Jacksonville, Florida
- Orlando, Florida
- Pensacola, Florida
- Vero Beach, Florida
- Athens, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Augusta, Georgia
- Columbus, Georgia
- Columbus, Georgia
- Decatur, Georgia
- Lincolnton, Georgia
- Savannah, Georgia
- Chicago, Illinois
- Chicago, Illinois
- Maywood, Illinois
- Merrillville, Indiana
- Overland Park, Kansas
- Bossier City, Louisiana
- New Orleans, Louisiana
- New Orleans, Louisiana
- Shreveport, Louisiana
- Shreveport, Louisiana
- Baltimore, Maryland
- Baltimore, Maryland
- Columbia, Maryland
- Randallstown, Maryland
- Rockville, Maryland
- Westminster, Maryland
- Brockton, Massachusetts
- Wellesley Hills, Massachusetts
- Detroit, Michigan
- Detroit, Michigan
- Lansing, Michigan
- Livonia, Michigan
- Jackson, Mississippi
- Jackson, Mississippi
- Kansas City, Missouri
- Kansas City, Missouri
- St. Louis, Missouri
- St. Louis, Missouri
- St. Louis, Missouri
- Cherry Hill, New Jersey
- East Orange, New Jersey
- Elizabeth, New Jersey
- Hammonton, New Jersey
- South Bound Brook, New Jersey
- Voorhees, New Jersey
- Woodbury, New Jersey
- Brooklyn, New York
- Brooklyn, New York
- Buffalo, New York
- Mineola, New York
- Charlotte, North Carolina
- Greenville, North Carolina
- Monroe, North Carolina
- Monroe, North Carolina
- Winston-Salem, North Carolina
- Winston-Salem, North Carolina
- Cincinnati, Ohio
- Cincinnati, Ohio
- Cincinnati, Ohio
- Cincinnati, Ohio
- Dayton, Ohio
- Dayton, Ohio
- Maumee, Ohio
- Perrysburg, Ohio
- Bensalem, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Bamberg, South Carolina
- Charleston, South Carolina
- Clinton, South Carolina
- Mt. Pleasant, South Carolina
- Simpsonville, South Carolina
- Bartlett, Tennessee
- Jackson, Tennessee
- Beaumont, Texas
- Dallas, Texas
- Dallas, Texas
- Houston, Texas
- Houston, Texas
- Houston, Texas
- Emporia, Virginia
- Norfolk, Virginia
- Norfolk, Virginia
- Richmond, Virginia
- Richmond, Virginia
- Viginia Beach, Virginia
- Virginia Beach, Virginia
- Milwaukee, Wisconsin
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population | |||
Official Title ICMJE | Clinical Utility Of Caduet In Simultaneously Achieving Blood Pressure And Lipid Endpoints In A Specific Patient Population (CAPABLE) | |||
Brief Summary | The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 4 | |||
Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment | |||
Condition ICMJE |
| |||
Intervention ICMJE | Drug: Amlodipine/Atorvastatin | |||
Study Arms ICMJE | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Completed | |||
Enrollment ICMJE | 500 | |||
Original Enrollment ICMJE | Same as current | |||
Actual Study Completion Date ICMJE | August 2005 | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 18 Years to 80 Years (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | Yes | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT00150384 | |||
Other Study ID Numbers ICMJE | A3841025 | |||
Has Data Monitoring Committee | Not Provided | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Pfizer ( Pfizer's Upjohn has merged with Mylan to form Viatris Inc. ) | |||
Study Sponsor ICMJE | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | January 2021 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |